tradingkey.logo
tradingkey.logo
Buscar

STAAR Surgical Co

STAA
Añadir a la lista de seguimiento
27.790USD
-0.360-1.28%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
1.38BCap. mercado
PérdidaP/E TTM

Más Datos de STAAR Surgical Co Compañía

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.

Información de STAAR Surgical Co

Símbolo de cotizaciónSTAA
Nombre de la empresaSTAAR Surgical Co
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoFarrell (Stephen C)
Número de empleados1157
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 24
Dirección1911 Walker Ave
CiudadMONROVIA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal91016
Teléfono16263037902
Sitio Webhttps://www.staar.com/
Símbolo de cotizaciónSTAA
Fecha de salida a bolsaFeb 24, 1992
Director ejecutivoFarrell (Stephen C)

Ejecutivos de STAAR Surgical Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
11.16K
+95.74%
Dr. Elizabeth Yeu, M.D.
Dr. Elizabeth Yeu, M.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
5.10K
--
Mr. Brian Moore
Mr. Brian Moore
Vice President - Investor Relations and Corporate Development
Vice President - Investor Relations and Corporate Development
--
--
Ms. Lilian Zhou
Ms. Lilian Zhou
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Stephen C. (Steve) Farrell, CPA
Mr. Stephen C. (Steve) Farrell, CPA
Chief Executive Officer, Director
Chief Executive Officer, Director
82.21K
+57.24%
Mr. Wei Jiang
Mr. Wei Jiang
Director
Director
78.19K
+13.66%
Mr. Warren Foust
Mr. Warren Foust
President, Chief Operating Officer
President, Chief Operating Officer
69.54K
+18.35%
Dr. Magda Michna, Ph.D.
Dr. Magda Michna, Ph.D.
Chief Development Officer
Chief Development Officer
33.42K
+25.17%
Mr. Nathaniel B. Sisitsky, Esq.
Mr. Nathaniel B. Sisitsky, Esq.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
30.18K
+72.87%
Ms. Deborah J. Andrews
Ms. Deborah J. Andrews
Chief Financial Officer
Chief Financial Officer
18.65K
+53.97%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de STAAR Surgical Co?

Los cinco principales accionistas de STAAR Surgical Co son: Mr. Stephen C. (Steve) Farrell, CPA

¿Cuántas instituciones poseen acciones de STAAR Surgical Co (STAA)?

A fecha de 2026Q1, 543 instituciones poseen acciones de STAAR Surgical Co, con un valor de mercado combinado de aproximadamente 58.06M, lo que representa el 116.62% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -10575638.00.